Table of Contents Executive Summary 1 Industry Overview of Proliferative Vitreoretinopathy (PVR) Therapeutics 1.1 Definition of Proliferative Vitreoretinopathy (PVR) Therapeutics 1.2 Proliferative Vitreoretinopathy (PVR) Therapeutics Segment by Type 1.2.1 Global Proliferative Vitreoretinopathy (PVR) Therapeutics Production Growth Rate Comparison by Types (2014-2025) 1.2.2 PRM-167 1.2.3 XOMA-089 1.2.4 Others 1.3 Proliferative Vitreoretinopathy (PVR) Therapeutics Segment by Applications 1.3.1 Global Proliferative Vitreoretinopathy (PVR) Therapeutics Consumption Comparison by Applications (2014-2025) 1.3.2 Hospital 1.3.3 Clinic 1.3.4 ASCs 1.3.5 Others 1.4 Global Proliferative Vitreoretinopathy (PVR) Therapeutics Overall Market 1.4.1 Global Proliferative Vitreoretinopathy (PVR) Therapeutics Revenue (2014-2025) 1.4.2 Global Proliferative Vitreoretinopathy (PVR) Therapeutics Production (2014-2025) 1.4.3 North America Proliferative Vitreoretinopathy (PVR) Therapeutics Status and Prospect (2014-2025) 1.4.4 Europe Proliferative Vitreoretinopathy (PVR) Therapeutics Status and Prospect (2014-2025) 1.4.5 China Proliferative Vitreoretinopathy (PVR) Therapeutics Status and Prospect (2014-2025) 1.4.6 Japan Proliferative Vitreoretinopathy (PVR) Therapeutics Status and Prospect (2014-2025) 1.4.7 Southeast Asia Proliferative Vitreoretinopathy (PVR) Therapeutics Status and Prospect (2014-2025) 1.4.8 India Proliferative Vitreoretinopathy (PVR) Therapeutics Status and Prospect (2014-2025) 2 Manufacturing Cost Structure Analysis 2.1 Raw Material and Suppliers 2.2 Manufacturing Cost Structure Analysis of Proliferative Vitreoretinopathy (PVR) Therapeutics 2.3 Manufacturing Process Analysis of Proliferative Vitreoretinopathy (PVR) Therapeutics 2.4 Industry Chain Structure of Proliferative Vitreoretinopathy (PVR) Therapeutics 3 Development and Manufacturing Plants Analysis of Proliferative Vitreoretinopathy (PVR) Therapeutics 3.1 Capacity and Commercial Production Date 3.2 Global Proliferative Vitreoretinopathy (PVR) Therapeutics Manufacturing Plants Distribution 3.3 Major Manufacturers Technology Source and Market Position of Proliferative Vitreoretinopathy (PVR) Therapeutics 3.4 Recent Development and Expansion Plans 4 Key Figures of Major Manufacturers 4.1 Proliferative Vitreoretinopathy (PVR) Therapeutics Production and Capacity Analysis 4.2 Proliferative Vitreoretinopathy (PVR) Therapeutics Revenue Analysis 4.3 Proliferative Vitreoretinopathy (PVR) Therapeutics Price Analysis 4.4 Market Concentration Degree 5 Proliferative Vitreoretinopathy (PVR) Therapeutics Regional Market Analysis 5.1 Proliferative Vitreoretinopathy (PVR) Therapeutics Production by Regions 5.1.1 Global Proliferative Vitreoretinopathy (PVR) Therapeutics Production by Regions 5.1.2 Global Proliferative Vitreoretinopathy (PVR) Therapeutics Revenue by Regions 5.2 Proliferative Vitreoretinopathy (PVR) Therapeutics Consumption by Regions 5.3 North America Proliferative Vitreoretinopathy (PVR) Therapeutics Market Analysis 5.3.1 North America Proliferative Vitreoretinopathy (PVR) Therapeutics Production 5.3.2 North America Proliferative Vitreoretinopathy (PVR) Therapeutics Revenue 5.3.3 Key Manufacturers in North America 5.3.4 North America Proliferative Vitreoretinopathy (PVR) Therapeutics Import and Export 5.4 Europe Proliferative Vitreoretinopathy (PVR) Therapeutics Market Analysis 5.4.1 Europe Proliferative Vitreoretinopathy (PVR) Therapeutics Production 5.4.2 Europe Proliferative Vitreoretinopathy (PVR) Therapeutics Revenue 5.4.3 Key Manufacturers in Europe 5.4.4 Europe Proliferative Vitreoretinopathy (PVR) Therapeutics Import and Export 5.5 China Proliferative Vitreoretinopathy (PVR) Therapeutics Market Analysis 5.5.1 China Proliferative Vitreoretinopathy (PVR) Therapeutics Production 5.5.2 China Proliferative Vitreoretinopathy (PVR) Therapeutics Revenue 5.5.3 Key Manufacturers in China 5.5.4 China Proliferative Vitreoretinopathy (PVR) Therapeutics Import and Export 5.6 Japan Proliferative Vitreoretinopathy (PVR) Therapeutics Market Analysis 5.6.1 Japan Proliferative Vitreoretinopathy (PVR) Therapeutics Production 5.6.2 Japan Proliferative Vitreoretinopathy (PVR) Therapeutics Revenue 5.6.3 Key Manufacturers in Japan 5.6.4 Japan Proliferative Vitreoretinopathy (PVR) Therapeutics Import and Export 5.7 Southeast Asia Proliferative Vitreoretinopathy (PVR) Therapeutics Market Analysis 5.7.1 Southeast Asia Proliferative Vitreoretinopathy (PVR) Therapeutics Production 5.7.2 Southeast Asia Proliferative Vitreoretinopathy (PVR) Therapeutics Revenue 5.7.3 Key Manufacturers in Southeast Asia 5.7.4 Southeast Asia Proliferative Vitreoretinopathy (PVR) Therapeutics Import and Export 5.8 India Proliferative Vitreoretinopathy (PVR) Therapeutics Market Analysis 5.8.1 India Proliferative Vitreoretinopathy (PVR) Therapeutics Production 5.8.2 India Proliferative Vitreoretinopathy (PVR) Therapeutics Revenue 5.8.3 Key Manufacturers in India 5.8.4 India Proliferative Vitreoretinopathy (PVR) Therapeutics Import and Export 6 Proliferative Vitreoretinopathy (PVR) Therapeutics Segment Market Analysis (by Type) 6.1 Global Proliferative Vitreoretinopathy (PVR) Therapeutics Production by Type 6.2 Global Proliferative Vitreoretinopathy (PVR) Therapeutics Revenue by Type 6.3 Proliferative Vitreoretinopathy (PVR) Therapeutics Price by Type 7 Proliferative Vitreoretinopathy (PVR) Therapeutics Segment Market Analysis (by Application) 7.1 Global Proliferative Vitreoretinopathy (PVR) Therapeutics Consumption by Application 7.2 Global Proliferative Vitreoretinopathy (PVR) Therapeutics Consumption Market Share by Application (2014-2019) 8 Proliferative Vitreoretinopathy (PVR) Therapeutics Major Manufacturers Analysis 8.1 Novartis AG 8.1.1 Novartis AG Proliferative Vitreoretinopathy (PVR) Therapeutics Production Sites and Area Served 8.1.2 Novartis AG Product Introduction, Application and Specification 8.1.3 Novartis AG Proliferative Vitreoretinopathy (PVR) Therapeutics Production, Revenue, Ex-factory Price and Gross Margin (2014-2019) 8.1.4 Main Business and Markets Served 8.2 Promedior Inc 8.2.1 Promedior Inc Proliferative Vitreoretinopathy (PVR) Therapeutics Production Sites and Area Served 8.2.2 Promedior Inc Product Introduction, Application and Specification 8.2.3 Promedior Inc Proliferative Vitreoretinopathy (PVR) Therapeutics Production, Revenue, Ex-factory Price and Gross Margin (2014-2019) 8.2.4 Main Business and Markets Served 8.3 RXi Pharmaceuticals Corp 8.3.1 RXi Pharmaceuticals Corp Proliferative Vitreoretinopathy (PVR) Therapeutics Production Sites and Area Served 8.3.2 RXi Pharmaceuticals Corp Product Introduction, Application and Specification 8.3.3 RXi Pharmaceuticals Corp Proliferative Vitreoretinopathy (PVR) Therapeutics Production, Revenue, Ex-factory Price and Gross Margin (2014-2019) 8.3.4 Main Business and Markets Served 9 Development Trend of Analysis of Proliferative Vitreoretinopathy (PVR) Therapeutics Market 9.1 Global Proliferative Vitreoretinopathy (PVR) Therapeutics Market Trend Analysis 9.1.1 Global Proliferative Vitreoretinopathy (PVR) Therapeutics Market Size (Volume and Value) Forecast 2019-2025 9.2 Proliferative Vitreoretinopathy (PVR) Therapeutics Regional Market Trend 9.2.1 North America Proliferative Vitreoretinopathy (PVR) Therapeutics Forecast 2019-2025 9.2.2 Europe Proliferative Vitreoretinopathy (PVR) Therapeutics Forecast 2019-2025 9.2.3 China Proliferative Vitreoretinopathy (PVR) Therapeutics Forecast 2019-2025 9.2.4 Japan Proliferative Vitreoretinopathy (PVR) Therapeutics Forecast 2019-2025 9.2.5 Southeast Asia Proliferative Vitreoretinopathy (PVR) Therapeutics Forecast 2019-2025 9.2.6 India Proliferative Vitreoretinopathy (PVR) Therapeutics Forecast 2019-2025 9.3 Proliferative Vitreoretinopathy (PVR) Therapeutics Market Trend (Product Type) 9.4 Proliferative Vitreoretinopathy (PVR) Therapeutics Market Trend (Application) 10.1 Marketing Channel 10.1.1 Direct Marketing 10.1.2 Indirect Marketing 10.3 Proliferative Vitreoretinopathy (PVR) Therapeutics Customers 11 Market Dynamics 11.1 Market Trends 11.2 Opportunities 11.3 Market Drivers 11.4 Challenges 11.5 Influence Factors 12 Conclusion 13 Appendix 13.1 Methodology/Research Approach 13.1.1 Research Programs/Design 13.1.2 Market Size Estimation 13.1.3 Market Breakdown and Data Triangulation 13.2 Data Source 13.2.1 Secondary Sources 13.2.2 Primary Sources 13.3 Author List 13.4 Disclaimer

List of Tables and Figures Figure Picture of Proliferative Vitreoretinopathy (PVR) Therapeutics Table Global Proliferative Vitreoretinopathy (PVR) Therapeutics Production (K Pcs) Growth Rate Comparison by Types (2014-2025) Figure Global Proliferative Vitreoretinopathy (PVR) Therapeutics Production Market Share by Types in 2018 Figure PRM-167 Product Picture Figure XOMA-089 Product Picture Figure Others Product Picture Table Global Proliferative Vitreoretinopathy (PVR) Therapeutics Consumption (K Pcs) Comparison by Applications (2014-2025) Figure Global Proliferative Vitreoretinopathy (PVR) Therapeutics Consumption Market Share by Applications in 2018 Figure Hospital Figure Clinic Figure ASCs Figure Others Figure Global Proliferative Vitreoretinopathy (PVR) Therapeutics Revenue (Million USD) (2014-2025) Figure Global Proliferative Vitreoretinopathy (PVR) Therapeutics Production (K Pcs) (2014-2025) Figure North America Proliferative Vitreoretinopathy (PVR) Therapeutics Market Size (Million USD) (2014-2025) Figure Europe Proliferative Vitreoretinopathy (PVR) Therapeutics Market Size (Million USD) (2014-2025) Figure China Proliferative Vitreoretinopathy (PVR) Therapeutics Market Size (Million USD) (2014-2025) Figure Japan Proliferative Vitreoretinopathy (PVR) Therapeutics Market Size (Million USD) (2014-2025) Figure Southeast Asia Proliferative Vitreoretinopathy (PVR) Therapeutics Market Size (Million USD) (2014-2025) Figure India Proliferative Vitreoretinopathy (PVR) Therapeutics Market Size (Million USD) (2014-2025) Table Proliferative Vitreoretinopathy (PVR) Therapeutics Raw Material and Suppliers Table Manufacturing Cost Structure Analysis of Proliferative Vitreoretinopathy (PVR) Therapeutics in 2018 Figure Manufacturing Process Analysis of Proliferative Vitreoretinopathy (PVR) Therapeutics Figure Industry Chain Structure of Proliferative Vitreoretinopathy (PVR) Therapeutics Table Capacity and Commercial Production Date of Key Manufacturers Table Global Proliferative Vitreoretinopathy (PVR) Therapeutics Manufacturing Plants Distribution Table Proliferative Vitreoretinopathy (PVR) Therapeutics Major Manufacturers Technology Source and Market Position Table Recent Development and Expansion Plans in Future Table Proliferative Vitreoretinopathy (PVR) Therapeutics Capacity (K Pcs) of Major Manufacturers (2014-2019) Table Proliferative Vitreoretinopathy (PVR) Therapeutics Production (K Pcs) of Major Manufacturers (2014-2019) Table Proliferative Vitreoretinopathy (PVR) Therapeutics Production Market Share of Major Manufacturers (2014-2019) Figure Proliferative Vitreoretinopathy (PVR) Therapeutics Production Share by Manufacturers in 2018 Table Proliferative Vitreoretinopathy (PVR) Therapeutics Revenue (Million US$) of Major Manufacturers (2014-2019) Table Proliferative Vitreoretinopathy (PVR) Therapeutics Revenue Market Share of Major Manufacturers (2014-2019) Figure Proliferative Vitreoretinopathy (PVR) Therapeutics Revenue Share by Manufacturers in 2018 Table Proliferative Vitreoretinopathy (PVR) Therapeutics Average Price (USD/Pcs) of Major Manufacturers (2014-2019) Table Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table Global Proliferative Vitreoretinopathy (PVR) Therapeutics Production by Regions 2014-2019 (K Pcs) Table Global Proliferative Vitreoretinopathy (PVR) Therapeutics Production Market Share by Regions 2014-2019 Figure Global Proliferative Vitreoretinopathy (PVR) Therapeutics Production Market Share by Regions in 2018 Table Global Proliferative Vitreoretinopathy (PVR) Therapeutics Revenue by Regions 2014-2019 (Million USD) Table Global Proliferative Vitreoretinopathy (PVR) Therapeutics Revenue Market Share by Regions 2014-2019 Figure Global Proliferative Vitreoretinopathy (PVR) Therapeutics Revenue Market Share by Regions in 2018 Table Global Proliferative Vitreoretinopathy (PVR) Therapeutics Consumption by Regions 2014-2019 (K Pcs) Table Global Proliferative Vitreoretinopathy (PVR) Therapeutics Consumption Market Share by Regions 2014-2019 Figure North America Proliferative Vitreoretinopathy (PVR) Therapeutics Production Growth Rate 2014-2019 (K Pcs) Figure North America Proliferative Vitreoretinopathy (PVR) Therapeutics Revenue Growth Rate 2014-2019 (Million USD) Table North America Proliferative Vitreoretinopathy (PVR) Therapeutics Production, Consumption Import and Export (K Pcs) Figure Europe Proliferative Vitreoretinopathy (PVR) Therapeutics Production Growth Rate 2014-2019 (K Pcs) Figure Europe Proliferative Vitreoretinopathy (PVR) Therapeutics Revenue Growth Rate 2014-2019 (Million USD) Table Europe Proliferative Vitreoretinopathy (PVR) Therapeutics Production, Consumption Import and Export (K Pcs) Figure China Proliferative Vitreoretinopathy (PVR) Therapeutics Production Growth Rate 2014-2019 (K Pcs) Figure China Proliferative Vitreoretinopathy (PVR) Therapeutics Revenue Growth Rate 2014-2019 (Million USD) Table China Proliferative Vitreoretinopathy (PVR) Therapeutics Production, Consumption Import and Export (K Pcs) Figure Japan Proliferative Vitreoretinopathy (PVR) Therapeutics Production Growth Rate 2014-2019 (K Pcs) Figure Japan Proliferative Vitreoretinopathy (PVR) Therapeutics Revenue Growth Rate 2014-2019 (Million USD) Table Japan Proliferative Vitreoretinopathy (PVR) Therapeutics Production, Consumption Import and Export (K Pcs) Figure Southeast Asia Proliferative Vitreoretinopathy (PVR) Therapeutics Production Growth Rate 2014-2019 (K Pcs) Figure Southeast Asia Proliferative Vitreoretinopathy (PVR) Therapeutics Revenue Growth Rate 2014-2019 (Million USD) Table Southeast Asia Proliferative Vitreoretinopathy (PVR) Therapeutics Production, Consumption Import and Export (K Pcs) Figure India Proliferative Vitreoretinopathy (PVR) Therapeutics Production Growth Rate 2014-2019 (K Pcs) Figure India Proliferative Vitreoretinopathy (PVR) Therapeutics Revenue Growth Rate 2014-2019 (Million USD) Table India Proliferative Vitreoretinopathy (PVR) Therapeutics Production, Consumption Import and Export (K Pcs) Figure Global Consumption Proliferative Vitreoretinopathy (PVR) Therapeutics Market Share by Application (2014-2019) Figure Global Value (Consumption) Proliferative Vitreoretinopathy (PVR) Therapeutics Market Share by Application (2014-2019) Table Novartis AG Proliferative Vitreoretinopathy (PVR) Therapeutics Production Sites and Area Served Table Novartis AG Proliferative Vitreoretinopathy (PVR) Therapeutics Product Introduction, Application and Specification Table Novartis AG Proliferative Vitreoretinopathy (PVR) Therapeutics Production (K Pcs), Revenue (Million USD), Ex-factory Price (USD/Pcs) and Gross Margin (2014-2019) Table Novartis AG Proliferative Vitreoretinopathy (PVR) Therapeutics Production Growth Rate (2014-2019) Table Novartis AG Proliferative Vitreoretinopathy (PVR) Therapeutics Production Market Share (2014-2019) Figure Novartis AG Proliferative Vitreoretinopathy (PVR) Therapeutics Revenue Market Share (2014-2019) Table Novartis AG Proliferative Vitreoretinopathy (PVR) Therapeutics Main Business and Markets Served Table Promedior Inc Proliferative Vitreoretinopathy (PVR) Therapeutics Production Sites and Area Served Table Promedior Inc Proliferative Vitreoretinopathy (PVR) Therapeutics Product Introduction, Application and Specification Table Promedior Inc Proliferative Vitreoretinopathy (PVR) Therapeutics Production (K Pcs), Revenue (Million USD), Ex-factory Price (USD/Pcs) and Gross Margin (2014-2019) Table Promedior Inc Proliferative Vitreoretinopathy (PVR) Therapeutics Production Growth Rate (2014-2019) Table Promedior Inc Proliferative Vitreoretinopathy (PVR) Therapeutics Production Market Share (2014-2019) Figure Promedior Inc Proliferative Vitreoretinopathy (PVR) Therapeutics Revenue Market Share (2014-2019) Table Promedior Inc Proliferative Vitreoretinopathy (PVR) Therapeutics Main Business and Markets Served Table RXi Pharmaceuticals Corp Proliferative Vitreoretinopathy (PVR) Therapeutics Production Sites and Area Served Table RXi Pharmaceuticals Corp Proliferative Vitreoretinopathy (PVR) Therapeutics Product Introduction, Application and Specification Table RXi Pharmaceuticals Corp Proliferative Vitreoretinopathy (PVR) Therapeutics Production (K Pcs), Revenue (Million USD), Ex-factory Price (USD/Pcs) and Gross Margin (2014-2019) Table RXi Pharmaceuticals Corp Proliferative Vitreoretinopathy (PVR) Therapeutics Production Growth Rate (2014-2019) Table RXi Pharmaceuticals Corp Proliferative Vitreoretinopathy (PVR) Therapeutics Production Market Share (2014-2019) Figure RXi Pharmaceuticals Corp Proliferative Vitreoretinopathy (PVR) Therapeutics Revenue Market Share (2014-2019) Table RXi Pharmaceuticals Corp Proliferative Vitreoretinopathy (PVR) Therapeutics Main Business and Markets Served Figure Global Proliferative Vitreoretinopathy (PVR) Therapeutics Production (K Pcs) Growth Rate Forecast 2019-2025 Figure Global Proliferative Vitreoretinopathy (PVR) Therapeutics Revenue (Million USD) Growth Rate Forecast 2019-2025 Figure Global Proliferative Vitreoretinopathy (PVR) Therapeutics Sales Price (USD/Pcs) Forecast 2019-2025 Figure North America Proliferative Vitreoretinopathy (PVR) Therapeutics Production Growth Rate Forecast 2019-2025 (K Pcs) Figure North America Proliferative Vitreoretinopathy (PVR) Therapeutics Revenue Growth Rate Forecast 2019-2025 (Million USD) Figure Europe Proliferative Vitreoretinopathy (PVR) Therapeutics Production Growth Rate Forecast 2019-2025 (K Pcs) Figure Europe Proliferative Vitreoretinopathy (PVR) Therapeutics Revenue Growth Rate Forecast 2019-2025 (Million USD) Figure China Proliferative Vitreoretinopathy (PVR) Therapeutics Production Growth Rate Forecast 2019-2025 (K Pcs) Figure China Proliferative Vitreoretinopathy (PVR) Therapeutics Revenue Growth Rate Forecast 2019-2025 (Million USD) Figure Japan Proliferative Vitreoretinopathy (PVR) Therapeutics Production Growth Rate Forecast 2019-2025 (K Pcs) Figure Japan Proliferative Vitreoretinopathy (PVR) Therapeutics Revenue Growth Rate Forecast 2019-2025 (Million USD) Figure Southeast Asia Proliferative Vitreoretinopathy (PVR) Therapeutics Production Growth Rate Forecast 2019-2025 (K Pcs) Figure Southeast Asia Proliferative Vitreoretinopathy (PVR) Therapeutics Revenue Growth Rate Forecast 2019-2025 (Million USD) Figure India Proliferative Vitreoretinopathy (PVR) Therapeutics Production Growth Rate Forecast 2019-2025 (K Pcs) Figure India Proliferative Vitreoretinopathy (PVR) Therapeutics Revenue Growth Rate Forecast 2019-2025 (Million USD) Table Global Production (K Pcs) of Proliferative Vitreoretinopathy (PVR) Therapeutics by Type (2019-2025) Table Global Consumption (K Pcs) of Proliferative Vitreoretinopathy (PVR) Therapeutics by Application (2019-2025) Table Proliferative Vitreoretinopathy (PVR) Therapeutics Distributors List Table Proliferative Vitreoretinopathy (PVR) Therapeutics Customers List Table Market Key Trends Table Key Opportunities Table Market Key Drivers Table Key Challenges Table Key Influence Factors Table Research Programs/Design for This Report Figure Bottom-up and Top-down Approaches for This Report Figure Data Triangulation Table Key Data Information from Secondary Sources Table Key Data Information from Primary Sources

Novartis AG Promedior Inc RXi Pharmaceuticals Corp